AKT1 and cancer: Studies have suggested that AKT/mTOR inhibition suppresses the proliferation, migration, and survival of cancer cells while strengthening the immune surveillance of tumors by preventing immunosuppressive pathways from activating and enhancing the innate immunity against tumors [21–23].